 |
BioWorld-International-2003-10-08
Arrow Raises £21M In First Closing Of Second Round
Arrow Raises £21M In First Closing Of Second Round
LONDON - Arrow Therapeutics Ltd. raised more than £21 million in the first close of its second-round funding, which should enable it to advance two antiviral products into clinical trials next year and complete preclinical development of antibacterial leads. (BioWorld International)